Collectively, NNMT’s master regulatory involvement in key metabolic processes in the metabolically active tissues (adipose, liver, and muscle) suggests that NNMT may represent an attractive, druggable target serving as a niche access point to treat obesity and related chronic metabolic diseases. This evidence concerns the gene NNMT and obesity disorder.